BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524548

SHARMEH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SHARMA EAST INDIA HOSPITALS & Share Price Update

As of the latest trading session, SHARMA EAST INDIA HOSPITALS & share price is currently at ₹ 212.23, which is up by ₹ 10.09 from its previous closing. Today, the stock has fluctuated between ₹ 212.23 and ₹ 212.23. Over the past year, SHARMA EAST INDIA HOSPITALS & has achieved a return of 97.64 %. In the last month alone, the return has been 162.36 %. Read More...

Investment Returns

Over 1 Month 162.36% Over 3 Months 172.08% Over 6 Months 205.80% Over 1 Year 97.64%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SHARMA EAST INDIA HOSPITALS & fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    69.60

  • P/E Ratio (TTM)

    53.06

  • Beta

    0.40

  • Book Value / share

    35.36

  • Return on equity

    -40.00%

  • EPS (TTM)

    4.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.32

info icon alternate text

SHARMA EAST INDIA HOSPITALS & Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 9.47
Operating Expense 9.08
Net Profit 0.32
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 0.97
EBITDA 0.96
Effective Tax Rate (%) 25.58
Particulars MAR 2025 (Values in Cr)
Revenue 5.98
Operating Expense 5.98
Net Profit 0.37
Net Profit Margin (%) 6.18
Earnings Per Share (EPS) 1.12
EBITDA 1.04
Effective Tax Rate (%) -60.86
Particulars DEC 2024 (Values in Cr)
Revenue 8.15
Operating Expense 7.80
Net Profit 0.29
Net Profit Margin (%) 3.55
Earnings Per Share (EPS) 0.88
EBITDA 0.90
Effective Tax Rate (%) 25.64
Particulars SEP 2024 (Values in Cr)
Revenue 9.02
Operating Expense 8.60
Net Profit 0.34
Net Profit Margin (%) 3.76
Earnings Per Share (EPS) 1.03
EBITDA 1.15
Effective Tax Rate (%) 26.08
Particulars JUN 2024 (Values in Cr)
Revenue 6.72
Operating Expense 6.38
Net Profit 0.25
Net Profit Margin (%) 3.72
Earnings Per Share (EPS) 0.77
EBITDA 0.86
Effective Tax Rate (%) 26.47
Particulars MAR 2025 (Values in Cr)
Revenue 29.87
Operating Expense 28.77
Net Profit 1.24
Net Profit Margin (%) 4.15
Earnings Per Share (EPS) 3.79
EBITDA 3.96
Effective Tax Rate (%) 12.05
Particulars MAR 2024 (Values in Cr)
Revenue 18.52
Operating Expense 22.83
Net Profit 0.66
Net Profit Margin (%) 3.56
Earnings Per Share (EPS) 2.02
EBITDA 3.42
Effective Tax Rate (%) 34.00
Particulars MAR 2023 (Values in Cr)
Revenue 20.73
Operating Expense 20.00
Net Profit 0.83
Net Profit Margin (%) 4.00
Earnings Per Share (EPS) 2.96
EBITDA 3.36
Effective Tax Rate (%) -5.06
Particulars MAR 2022 (Values in Cr)
Revenue 17.04
Operating Expense 16.26
Net Profit 0.68
Net Profit Margin (%) 3.99
Earnings Per Share (EPS) 2.07
EBITDA 2.30
Effective Tax Rate (%) 18.07
Particulars MAR 2021 (Values in Cr)
Revenue 8.13
Operating Expense 10.12
Net Profit 0.64
Net Profit Margin (%) 7.87
Earnings Per Share (EPS) 1.94
EBITDA 2.17
Effective Tax Rate (%) 23.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 27.02
ROE % -40.00
ROCE % -18.61
Total Debt to Total Equity 0.61
EBITDA Margin -9.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.42
ROE % 8.23
ROCE % 12.00
Total Debt to Total Equity 0.63
EBITDA Margin 16.21
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.08
ROE % 7.34
ROCE % 10.48
Total Debt to Total Equity 0.56
EBITDA Margin 13.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 21.45
ROE % -22.67
ROCE % -8.06
Total Debt to Total Equity 0.78
EBITDA Margin -7.63
Particulars MAR 2020 (Values in Cr)
Book Value / Share 19.91
ROE % 3.83
ROCE % 8.65
Total Debt to Total Equity 1.13
EBITDA Margin 12.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 25.16
Total Liabilities 25.16
Total Equity 11.23
Share Outstanding 3283800
Price to Book Ratio 0.00
Return on Assets (%) 2.63
Return on Capital (%) 4.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 23.71
Total Liabilities 23.71
Total Equity 10.56
Share Outstanding 3283800
Price to Book Ratio 0.00
Return on Assets (%) 3.51
Return on Capital (%) 4.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 19.05
Total Liabilities 19.05
Total Equity 9.59
Share Outstanding 3283800
Price to Book Ratio 0.00
Return on Assets (%) 3.56
Return on Capital (%) 4.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.21
Total Assets 18.87
Total Liabilities 18.87
Total Equity 8.91
Share Outstanding 3283800
Price to Book Ratio 0.00
Return on Assets (%) 3.37
Return on Capital (%) 4.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 19.85
Total Liabilities 19.85
Total Equity 8.27
Share Outstanding 3283800
Price to Book Ratio 0.00
Return on Assets (%) 1.54
Return on Capital (%) 2.02
Particulars MAR 2024 (Values in Cr)
Net Income 1.00
Cash from Operations -0.83
Cash from Investing 5.16
Cash from Financing -4.20
Net change in Cash -0.17
Free Cash Flow 0.70
Particulars MAR 2023 (Values in Cr)
Net Income 0.79
Cash from Operations 1.27
Cash from Investing -3.63
Cash from Financing 2.76
Net change in Cash 0.41
Free Cash Flow 4.91
Particulars MAR 2022 (Values in Cr)
Net Income 0.83
Cash from Operations 2.16
Cash from Investing -2.11
Cash from Financing -1.77
Net change in Cash -1.86
Free Cash Flow 4.28
Particulars MAR 2021 (Values in Cr)
Net Income 0.83
Cash from Operations 1.53
Cash from Investing 2.78
Cash from Financing -2.15
Net change in Cash 2.02
Free Cash Flow 1.89
Particulars MAR 2020 (Values in Cr)
Net Income 0.37
Cash from Operations 1.27
Cash from Investing -1.49
Cash from Financing -4.74
Net change in Cash -5.03
Free Cash Flow 2.77
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7606.75 69.51 13.33 109373.39 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.18 27.31 4.16 125.91 51.01 / 98.70
SHREE PACETRONIX LTD. 164.06 56.57 4.28 59.05 61.11 / 192.00
TRANSGENE BIOTEK LTD. 3.88 0.00 2.93 29.40 3.22 / 9.07
VIMTA LABS LIMITED 666.10 48.76 8.64 2964.52 254.43 / 728.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7606.75 80.93 12.52 109373.39 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.00 0.00 -15.01 28.39 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6343.55 31.48 6.38 6939.84 4777.15 / 6525.00

SHARMA EAST INDIA HOSPITALS & Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
212.23 4.99 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 191.00
  • 26 Days 128.20
  • 10 Days 167.20
  • 50 Days 108.00
  • 12 Days 159.60
  • 100 Days 95.20
  • 20 Days 138.20
  • 200 Days 87.80
202.09 PIVOT

First Support

202.04

First Resistance

202.17

Second Support

201.96

Second Resistance

202.22

Third Support

201.91

Third Resistance

202.30

RSI

94.00

ADX

72.72

MACD

31.41

Williams % R

0.00

Commodity Channel Index (CCI)

148.15

Date

2025-08-29

Week

4228.00

Same Day

3754.00

Month

2319.00

1 Year

0.41

3 Year

0.26

Over 1 Month

162.36%

down

Over 1 Year

97.64%

down

Over 3 Months

172.08%

down

Over 3 Years

0.00%

down

Over 6 Months

205.80%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

SHARMA EAST INDIA HOSPITALS & shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

SHARMA EAST INDIA HOSPITALS & corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SHARMA EAST INDIA HOSPITALS & Share Price

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989. The Company is primarily engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name and style of 'Jaipur Hospital' at Lal Kothi, Jaipur, Rajasthan since 1989.

As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India. It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery. NABH accreditation is a scarce jewel for the Company. Performance of the organization against the stated mission is achieved by the increase in number of patients.

The Company has launched the S-ROM Modular Hip System, the most advanced artificial hip implant designed to reduce stiffness and thigh pain. The hospital is providing the service of Heart Surgery. The hospital is also providing the service of Replacement surgery through the use of new and advance implant.

The Company is first in the state of Rajasthan which performed 'Replacement Surgery'. The specially designed state of the art operation theatre is first of its kind in Rajasthan. This theatre has total body exhaust system and 'Antistatic' flooring which makes it totally sterile. That's why, Company became successful in getting reorganization from many reputed Govt. Bodies/Corporations/Banks and other private enterprises for reimbursement of medical claims of their employees being treated at the hospital.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sharma East India Hosp and Medical Research Ltd?

Answer Field

Sharma East India Hosp and Medical Research Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 212.23 as on Aug 29 2025 03:14 PM.

What is the Market Cap of Sharma East India Hosp and Medical Research Ltd Share?

Answer Field

The market cap of Sharma East India Hosp and Medical Research Ltd for NSE ₹ 0.00 & for BSE ₹ 69.60 as on Aug 29 2025 03:14 PM.

What is the 52 Week High and Low of Sharma East India Hosp and Medical Research Ltd?

Answer Field

The 52 Week High and Low of Sharma East India Hosp and Medical Research Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 212.23 and ₹ 39.75.

What is 1 year return for Sharma East India Hosp and Medical Research Ltd?

Answer Field

The 1 year returns on the stock has been 97.64%.

What is the P/E Ratio of Sharma East India Hosp and Medical Research Ltd Share?

Answer Field

As on Aug 29 2025 03:14 PM the price-to-earnings (PE) ratio for Sharma East India Hosp and Medical Research Ltd share is 53.06.

What is the PB ratio of Sharma East India Hosp and Medical Research Ltd Share?

Answer Field

As on Aug 29 2025 03:14 PM, the price-to-book (PB) ratio for Sharma East India Hosp and Medical Research Ltd share is 35.36.

How to Buy Sharma East India Hosp and Medical Research Ltd Share?

Answer Field

You can trade in Sharma East India Hosp and Medical Research Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sharma East India Hosp and Medical Research Ltd Share on Bajaj Broking App?

Answer Field

To buy Sharma East India Hosp and Medical Research Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sharma East India Hosp and Medical Research Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91